MariMed (OTCMKTS:MRMD – Get Free Report) and OrthoPediatrics (NASDAQ:KIDS – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.
Earnings & Valuation
This table compares MariMed and OrthoPediatrics”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| MariMed | $159.83 million | 0.12 | -$14.48 million | ($0.04) | -1.23 |
| OrthoPediatrics | $236.35 million | 3.36 | -$39.65 million | ($1.43) | -21.28 |
MariMed has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than MariMed, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares MariMed and OrthoPediatrics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| MariMed | -9.13% | -10.71% | -2.58% |
| OrthoPediatrics | -12.83% | -8.08% | -5.46% |
Institutional and Insider Ownership
0.2% of MariMed shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 16.1% of MariMed shares are owned by company insiders. Comparatively, 32.5% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Volatility and Risk
MariMed has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and target prices for MariMed and OrthoPediatrics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| MariMed | 0 | 2 | 0 | 0 | 2.00 |
| OrthoPediatrics | 1 | 1 | 7 | 0 | 2.67 |
OrthoPediatrics has a consensus price target of $30.75, indicating a potential upside of 1.05%. Given OrthoPediatrics’ stronger consensus rating and higher probable upside, analysts plainly believe OrthoPediatrics is more favorable than MariMed.
Summary
OrthoPediatrics beats MariMed on 8 of the 13 factors compared between the two stocks.
About MariMed
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
About OrthoPediatrics
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
